SOPHiA GENETICS (SOPH) Invested Capital (2020 - 2025)

SOPHiA GENETICS's Invested Capital history runs 6 years deep, the most recent figure standing at -$79.0 million for Q4 2025.

• In Q4 2025, Invested Capital fell 66.34% year-over-year to -$79.0 million; the TTM figure through Dec 2025 stood at -$79.0 million (down 66.34% YoY), while the FY2025 annual figure was -$79.0 million, down 66.34% from the prior year.
• Invested Capital came in at -$79.0 million for Q4 2025 at SOPHiA GENETICS, down from -$59.8 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $50.2 million in Q2 2022 to a low of -$87.4 million in Q4 2022.
• A 5-year average of -$30.7 million and a median of -$39.2 million in 2021 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital slumped 104.43% in 2021 and jumped 261.53% in 2022, its largest moves.
• SOPHiA GENETICS's Invested Capital stood at -$73.7 million in 2021, then decreased by 18.7% to -$87.4 million in 2022, then climbed by 9.68% to -$79.0 million in 2023, then jumped by 39.87% to -$47.5 million in 2024, then slumped by 66.34% to -$79.0 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered -$79.0 million, -$59.8 million, and $39.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison